Difference between revisions of "Bilski 35 USC § 101 Rejections Patent Application List"

From DolceraWiki
Jump to: navigation, search
Line 1: Line 1:
 +
== Bilski Medtech Sample ==
 
{|border="2" cellspacing="0" cellpadding="4" width="100%"
 
{|border="2" cellspacing="0" cellpadding="4" width="100%"
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''S.No'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''S.No'''</font>
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Publication <nowiki> </nowiki>'''</font>
+
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Publication No.'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Rejection type'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Rejection type'''</font>
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''101 rejection'''</font>
+
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''101 Rejection'''</font>
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Why 101 rejection'''</font>
+
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''102 Rejection'''</font>
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''Other rejection'''</font>
+
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''103 Rejection'''</font>
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''101 but not mentioning as claim rejection'''</font>
+
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''112 Rejection'''</font>
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''1'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''1'''</font>
Line 13: Line 14:
 
|N/A
 
|N/A
 
|N/A
 
|N/A
|103 rejection
+
|Claims 19-30 are rejected under 35 U.S.C. 103(a) as being unpatentable over Chaco et al., U.S. Patent 5,822,544 in view of Lichtman et al, U.S. Patent No. 5,819,107.
 
|N/A
 
|N/A
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''2'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''2'''</font>
 
|align = "center"|US20060189976A1
 
|align = "center"|US20060189976A1
|121 rejection
+
|Rejection information not available
 +
|N/A
 +
|N/A
 
|N/A
 
|N/A
 
|N/A
 
|N/A
|121 rejection
 
|The inventions are likely to raise different non-prior art issues under 35 U.S.C. 101 andlor 35 U.S.C. 11 2, first paragraph.
 
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''3'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''3'''</font>
Line 28: Line 29:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claims 1-26 and 41-54 rejected under 35 U.S.C. 102(e) as anticipated by or, in the alternative, under 35 U.S.C. 103(a) as obvious over Goldberger et al. (US Patent Application Publication US 200610079809).
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
Line 36: Line 37:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claims 1-3, 5, 8-1 3, 16-1 8, & 21 are rejected under 35 U.S.C. 102(b) as being anticipated by Bradley (US 200301 39781).
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''5'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''5'''</font>
 
|align = "center"|US20060194724A1
 
|align = "center"|US20060194724A1
|112 rejection
+
|103 and 112 rejection
|N/A
+
 
|N/A
 
|N/A
|112 rejection
 
 
|N/A
 
|N/A
 +
|The rejection of claims 1-1 6, 44-47, 49, 50-62, 64-70 are rejected under 35 U.S.C. 103(a) as being unpatentable over Shafik (Andrologia. 1996. 28: 151 -6) or Heiduschka et al. (Exp. Neurol. 2001. 171 : 1-10) in view of Burnett (World J. Urol, 2003.20: 337-342), US 6208894 (issued Mar 27,2001) and US 6464687 (issued Oct 15, 2002) is withdrawn in response to Applicant<nowiki>’</nowiki>s amendment to the claims and cancellation of claims 2, 7, 46, 52-70.
 +
|The rejection of claims 2, 7,46, 52-70 under 35 U.S.C. 112, first paragraph,<br>because the specification does not enable the invention commensurate in scope with<br>the claims is moot because the claims are canceled.
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''6'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''6'''</font>
Line 52: Line 53:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claims 1-12 and 21 are rejected under 35 U.S.C. 102(b) as being anticipated by<br>DiLorenzo (US 6,366,813).
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
Line 60: Line 61:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-21, 29-42, 43, and 45 are rejected under 35 U.S.C. 102(b) as being anticipated by Foley et al (US Pat: 6,167,145).
|102 and 103 rejection
+
|Claims 22-28 and 44 are rejected under 35 U.S.C. 103(a) as being unpatentable over Foley et al (US Pat: 6,167,145) stand alone.
 
|N/A
 
|N/A
 
|-
 
|-
Line 76: Line 77:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1, 3, 5-9, 11-14, 16, and 18-23 are rejected under 35 U.S.C. 102(b) as being anticipated by Cohen.
|102 and 103 rejection
+
|Claims 1, 3, 6-9, 11, 12, 14, 16, and 18-23 are rejected under 35 U.S.C. 103(a) as being unpatentable over Boveja, previously cited, in view of Tanagho, herein Boveja in view of Tanagho
 
|N/A
 
|N/A
 
|-
 
|-
Line 92: Line 93:
 
|112, 102 and 103 rejection
 
|112, 102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-2,25-26,35-37 are rejected under 35 U.S.C. 102(b) as being anticipated by "Detection of Atrial Persistent Rhythm Based on P-wave Recognition and RR Interval Variability" (VR Zurro, AL Stelle, and J Nadal, Computers in Cardiology 1995, as cited by Applicant and hereinafter referred to as "Zurro").
|112, 102 and 103 rejection
+
|Claims 3-5,27, and 38 are rejected under 35 U.S.C. 103(a) as being obvious over Bock.
|N/A
+
|Claims 24 and 34-45 are rejected under 35 U.S.C. 112, second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which applicant regards as the invention.
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''12'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''12'''</font>
Line 100: Line 101:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-1 3, 15-23, and 25-33 are rejected under 35 U.S.C. 102(e) as being anticipated by Gore et al. (US 2004101 47034).
|102 rejection
+
|  
 
|N/A
 
|N/A
 
|-
 
|-
Line 108: Line 109:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims I , 2,4, 5 are rejected under 35 U.S.C. 102(a) as being anticipated by Becker et al. (US Patent 6,904,161 BI).
|102 and 103 rejection
+
|Claims 3, 6-9 are rejected under 35 U.S.C. 103(a) as being unpatentable over Becker et al (US Patent 6,904,161 B1) in view of Lee (US Patent 4,838,75).
 
|N/A
 
|N/A
 
|-
 
|-
Line 124: Line 125:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claim 9 is rejected under 35 U.S.C. 102(b) as being anticipated by Vock et al (2003/0163287 A1)
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
Line 133: Line 134:
 
|N/A
 
|N/A
 
|N/A
 
|N/A
|103 rejection
+
|Claims 1-4, 7, 8, 11, 14, 17, 20-22, 27, 34 and 36 are rejected under 35 U.S.C. 103(a) as being unpatentable over Hedenstrom et al. (200210058674) and Mitra et al. (W0120021102377) in further view of Gordon et al. (20040014779).
 
|N/A
 
|N/A
 
|-
 
|-
Line 196: Line 197:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claims 1 and 3 rejected under 35 U.S.C. 102 (b) as being anticipated by White et al USPN 5,782,904.
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
Line 209: Line 210:
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''26'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''26'''</font>
|align = "center" bgcolor = "#CCFFFF"|[[Media:US20070034215A1.pdf|US20070034215A1]]
+
|align = "center"|US20070034215A1
|bgcolor = "#CCFFFF"|101 rejection
+
|101 rejection
|bgcolor = "#CCFFFF"|Claims 1-22 are rejected under 35 U.S.C. 101 for nonstatutory subject matter.
+
|Claims 1-22 are rejected under 35 U.S.C. 101 for nonstatutory subject matter. The invention is ineligible because it has not been limited to a substantial practical application and a tangible result. Instructions to transmit data does not result in a practical application and lacks a tangible result. The result has to be a practical application and a tangible result.
|bgcolor = "#CCFFFF"|The invention is ineligible because it has not been limited to a substantial practical application and a tangible result. Instructions to transmit data does not result in a practical application and lacks a tangible result. The result has to be a practical application and a tangible result.
+
|N/A
|bgcolor = "#CCFFFF"|N/A
+
|N/A
|bgcolor = "#CCFFFF"|
+
|N/A
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''27'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''27'''</font>
Line 220: Line 221:
 
|102 rejection
 
|102 rejection
 
|N/A
 
|N/A
 +
|Claims 1 - 19 are rejected under 35 U.S.C. 102(e) as being anticipated by Rogers et al. U.S. Patent No. 6,957,107.
 
|N/A
 
|N/A
|102 rejection
 
 
|N/A
 
|N/A
 
|-
 
|-
Line 252: Line 253:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 27, 28, 29, 35, 36, 37, 38, 39, 40, 45, 46, 47, 48, 49 are rejected under 35 U.S.C. 102(b) as being anticipated by Addison et al. (WO 2041075746).
|102 and 103 rejection
+
|Claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 41, 42, 43, 44, 50, 51, 52, and 53 are rejected under 35 U.S.C. 103(a) as being unpatentable over Addison in view of Prochazka et al article (Decomposition And Reconstruction Methods In Biomedical Image De-Noising, Proc. 1 6 th <nowiki>~</nowiki>ienniaIln t. EURASIP Conference BlOSlGNAL 2002, pp. 350-352, 2002)
 
|N/A
 
|N/A
 
|-
 
|-
Line 260: Line 261:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-3,6-10,25-29 & 31-34 are rejected under 35 U.S.C. 102(b) as being anticipated by Deno et al. (WO 031020364 A2).
|102 and 103 rejection
+
|Claims 4-5 & 30 are rejected under 35 U.S.C. 103(a) as being unpatentable over Deno et<br>al. (WO 031020364) in view of Frank et al. (US 5,265,615 A).
 
|N/A
 
|N/A
 
|-
 
|-
Line 268: Line 269:
 
|112 and 102 rejection
 
|112 and 102 rejection
 
|N/A
 
|N/A
 +
|Claims 1-1 2 and 19-23 are rejected under 35 U.S.C. 102(e) as being anticipated by Saracen et al (7,362,848)
 
|N/A
 
|N/A
|112 and 102 rejection
+
|Claims 1-23 are rejected under 35 U.S.C. 11 2, first paragraph, as failing to comply with the written description requirement.
|N/A
+
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''34'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''34'''</font>
Line 284: Line 285:
 
|112, 102 and 103 rejection
 
|112, 102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-3 are rejected under 35 U.S.C. 102(b) as being anticipated by Deckelbaum (U.S. Pat. No. 4,785,806).
|112, 102 and 103 rejection
+
|Claims 4-20 are rejected under 35 U.S.C. 103(a) as being unpatentable over Deckelbaum (U.S. Pat. No. 4,785,806) in view of Alfano et al (U.S. Pat. No. 5,293,872).
|N/A
+
|Claims 3, 7, 8 and 12 are rejected under 35 U.S.C. 112, first paragraph, as failing to comply with the written description requirement.
 
|-
 
|-
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''36'''</font>
 
|align = "center" bgcolor = "#808080"|<font color="#CCFFCC">'''36'''</font>
Line 292: Line 293:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1, 2, 8-12, 14-21, and 26-28 are rejected under 35 U.S.C. 102(b) as being anticipated by Funderburk (US Patent 2004101 331 64).
|102 and 103 rejection
+
|Claims 3-4 are rejected under 35 U.S.C. 103(a) as being unpatentable over Funderburk in view of Polcha (US Patent Application 2005101 97554).
 
|N/A
 
|N/A
 
|-
 
|-
Line 300: Line 301:
 
|102 and 103 rejection
 
|102 and 103 rejection
 
|N/A
 
|N/A
|N/A
+
|Claims 1-4, 6-7, 15-1 7, 19-22, 24-25, 34-36, 38, 40 and 45 are rejected under 35 U.S.C. 102(b) as being anticipated by Z-Kat (WO 20041070580) as cited by applicant.
|102 and 103 rejection
+
|Claims 5, 8-1 2, 18, 23, 26-31, 37, 39 and 41-42 are rejected under 35 U.S.C. 103(a) as being unpatentable over Z-Kat as applied to claims 1 and 19 above, and further in view of Krause et al. (US Patent No. 6,711,432).
 
|N/A
 
|N/A
 
|-
 
|-

Revision as of 02:06, 18 March 2009

Bilski Medtech Sample

S.No Publication No. Rejection type 101 Rejection 102 Rejection 103 Rejection 112 Rejection
1 US20060190302A1 103 rejection N/A N/A Claims 19-30 are rejected under 35 U.S.C. 103(a) as being unpatentable over Chaco et al., U.S. Patent 5,822,544 in view of Lichtman et al, U.S. Patent No. 5,819,107. N/A
2 US20060189976A1 Rejection information not available N/A N/A N/A N/A
3 US20060195058A1 102 rejection N/A Claims 1-26 and 41-54 rejected under 35 U.S.C. 102(e) as anticipated by or, in the alternative, under 35 U.S.C. 103(a) as obvious over Goldberger et al. (US Patent Application Publication US 200610079809). N/A N/A
4 US20060195159A1 102 rejection N/A Claims 1-3, 5, 8-1 3, 16-1 8, & 21 are rejected under 35 U.S.C. 102(b) as being anticipated by Bradley (US 200301 39781). N/A N/A
5 US20060194724A1 103 and 112 rejection N/A N/A The rejection of claims 1-1 6, 44-47, 49, 50-62, 64-70 are rejected under 35 U.S.C. 103(a) as being unpatentable over Shafik (Andrologia. 1996. 28: 151 -6) or Heiduschka et al. (Exp. Neurol. 2001. 171 : 1-10) in view of Burnett (World J. Urol, 2003.20: 337-342), US 6208894 (issued Mar 27,2001) and US 6464687 (issued Oct 15, 2002) is withdrawn in response to Applicants amendment to the claims and cancellation of claims 2, 7, 46, 52-70. The rejection of claims 2, 7,46, 52-70 under 35 U.S.C. 112, first paragraph,
because the specification does not enable the invention commensurate in scope with
the claims is moot because the claims are canceled.
6 US20060195144A1 102 rejection N/A Claims 1-12 and 21 are rejected under 35 U.S.C. 102(b) as being anticipated by
DiLorenzo (US 6,366,813).
N/A N/A
7 US20060200025A1 102 and 103 rejection N/A Claims 1-21, 29-42, 43, and 45 are rejected under 35 U.S.C. 102(b) as being anticipated by Foley et al (US Pat: 6,167,145). Claims 22-28 and 44 are rejected under 35 U.S.C. 103(a) as being unpatentable over Foley et al (US Pat: 6,167,145) stand alone. N/A
8 US20060200034A1 Rejection information not available N/A N/A N/A N/A
9 US20060200205A1 102 and 103 rejection N/A Claims 1, 3, 5-9, 11-14, 16, and 18-23 are rejected under 35 U.S.C. 102(b) as being anticipated by Cohen. Claims 1, 3, 6-9, 11, 12, 14, 16, and 18-23 are rejected under 35 U.S.C. 103(a) as being unpatentable over Boveja, previously cited, in view of Tanagho, herein Boveja in view of Tanagho N/A
10 US20060200011A1 Rejection information not available N/A N/A N/A N/A
11 US20060200036A1 112, 102 and 103 rejection N/A Claims 1-2,25-26,35-37 are rejected under 35 U.S.C. 102(b) as being anticipated by "Detection of Atrial Persistent Rhythm Based on P-wave Recognition and RR Interval Variability" (VR Zurro, AL Stelle, and J Nadal, Computers in Cardiology 1995, as cited by Applicant and hereinafter referred to as "Zurro"). Claims 3-5,27, and 38 are rejected under 35 U.S.C. 103(a) as being obvious over Bock. Claims 24 and 34-45 are rejected under 35 U.S.C. 112, second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which applicant regards as the invention.
12 US20060200071A1 102 rejection N/A Claims 1-1 3, 15-23, and 25-33 are rejected under 35 U.S.C. 102(e) as being anticipated by Gore et al. (US 2004101 47034). N/A
13 US20060203963A1 102 and 103 rejection N/A Claims I , 2,4, 5 are rejected under 35 U.S.C. 102(a) as being anticipated by Becker et al. (US Patent 6,904,161 BI). Claims 3, 6-9 are rejected under 35 U.S.C. 103(a) as being unpatentable over Becker et al (US Patent 6,904,161 B1) in view of Lee (US Patent 4,838,75). N/A
14 US20060206169A1 Rejection information not available N/A N/A N/A N/A
15 US20060212097A1 102 rejection N/A Claim 9 is rejected under 35 U.S.C. 102(b) as being anticipated by Vock et al (2003/0163287 A1) N/A N/A
16 US20060216333A1 103 rejection N/A N/A Claims 1-4, 7, 8, 11, 14, 17, 20-22, 27, 34 and 36 are rejected under 35 U.S.C. 103(a) as being unpatentable over Hedenstrom et al. (200210058674) and Mitra et al. (W0120021102377) in further view of Gordon et al. (20040014779). N/A
17 US20060276709A1 Rejection information not available N/A N/A N/A N/A
18 US20060276856A1 Rejection information not available N/A N/A N/A N/A
19 US20060281990A1 Rejection information not available N/A N/A N/A N/A
20 US20060281980A1 Rejection information not available N/A N/A N/A N/A
21 US20070027459A1 Rejection information not available N/A N/A N/A N/A
22 US20070027487A1 Rejection information not available N/A N/A N/A N/A
23 US20070032734A1 Rejection information not available N/A N/A N/A N/A
24 US20070032852A1 102 rejection N/A Claims 1 and 3 rejected under 35 U.S.C. 102 (b) as being anticipated by White et al USPN 5,782,904. N/A N/A
25 US20070038051A1 Rejection information not available N/A N/A N/A N/A
26 US20070034215A1 101 rejection Claims 1-22 are rejected under 35 U.S.C. 101 for nonstatutory subject matter. The invention is ineligible because it has not been limited to a substantial practical application and a tangible result. Instructions to transmit data does not result in a practical application and lacks a tangible result. The result has to be a practical application and a tangible result. N/A N/A N/A
27 US20070060797A1 102 rejection N/A Claims 1 - 19 are rejected under 35 U.S.C. 102(e) as being anticipated by Rogers et al. U.S. Patent No. 6,957,107. N/A N/A
28 US20070066904A1 Rejection information not available N/A N/A N/A N/A
29 US20070067190A1 Rejection information not available N/A N/A N/A N/A
30 US20070073180A1 Rejection information not available N/A N/A N/A N/A
31 US20070073124A1 102 and 103 rejection N/A Claims 27, 28, 29, 35, 36, 37, 38, 39, 40, 45, 46, 47, 48, 49 are rejected under 35 U.S.C. 102(b) as being anticipated by Addison et al. (WO 2041075746). Claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 30, 31, 32, 33, 34, 41, 42, 43, 44, 50, 51, 52, and 53 are rejected under 35 U.S.C. 103(a) as being unpatentable over Addison in view of Prochazka et al article (Decomposition And Reconstruction Methods In Biomedical Image De-Noising, Proc. 1 6 th ~ienniaIln t. EURASIP Conference BlOSlGNAL 2002, pp. 350-352, 2002) N/A
32 US20070073352A1 102 and 103 rejection N/A Claims 1-3,6-10,25-29 & 31-34 are rejected under 35 U.S.C. 102(b) as being anticipated by Deno et al. (WO 031020364 A2). Claims 4-5 & 30 are rejected under 35 U.S.C. 103(a) as being unpatentable over Deno et
al. (WO 031020364) in view of Frank et al. (US 5,265,615 A).
N/A
33 US20070078306A1 112 and 102 rejection N/A Claims 1-1 2 and 19-23 are rejected under 35 U.S.C. 102(e) as being anticipated by Saracen et al (7,362,848) N/A Claims 1-23 are rejected under 35 U.S.C. 11 2, first paragraph, as failing to comply with the written description requirement.
34 US20070078353A1 Rejection information not available N/A N/A N/A N/A
35 US20070078450A1 112, 102 and 103 rejection N/A Claims 1-3 are rejected under 35 U.S.C. 102(b) as being anticipated by Deckelbaum (U.S. Pat. No. 4,785,806). Claims 4-20 are rejected under 35 U.S.C. 103(a) as being unpatentable over Deckelbaum (U.S. Pat. No. 4,785,806) in view of Alfano et al (U.S. Pat. No. 5,293,872). Claims 3, 7, 8 and 12 are rejected under 35 U.S.C. 112, first paragraph, as failing to comply with the written description requirement.
36 US20070078320A1 102 and 103 rejection N/A Claims 1, 2, 8-12, 14-21, and 26-28 are rejected under 35 U.S.C. 102(b) as being anticipated by Funderburk (US Patent 2004101 331 64). Claims 3-4 are rejected under 35 U.S.C. 103(a) as being unpatentable over Funderburk in view of Polcha (US Patent Application 2005101 97554). N/A
37 US20070078678A1 102 and 103 rejection N/A Claims 1-4, 6-7, 15-1 7, 19-22, 24-25, 34-36, 38, 40 and 45 are rejected under 35 U.S.C. 102(b) as being anticipated by Z-Kat (WO 20041070580) as cited by applicant. Claims 5, 8-1 2, 18, 23, 26-31, 37, 39 and 41-42 are rejected under 35 U.S.C. 103(a) as being unpatentable over Z-Kat as applied to claims 1 and 19 above, and further in view of Krause et al. (US Patent No. 6,711,432). N/A
38 US20070078335A1 Rejection information not available N/A N/A N/A N/A
39 US20070083152A1 Rejection information not available N/A N/A N/A N/A
40 US20070088195A1 Rejection information not available N/A N/A N/A N/A